CDH2 and intrahepatic cholangiocarcinoma: Investigations into intrahepatic cholangiocarcinoma have demonstrated that stable ADM transfectants exhibit a marked upregulation of mesenchymal markers, such as vimentin and neural cadherin (N-cadherin), as well as epithelial-mesenchymal transition-associated transcription factors ZEB1 and ZEB2.